CAN
ADPT icon

Cetera Advisor Networks’s Adaptive Biotechnologies ADPT Stock Holding History

Cetera Advisor Networks’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-575
Closed -$28K – 1257
2020
Q2 		$28K Buy
+575
New +$21K ﹤0.01% 2216

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

Cetera Advisor Networks's ADPT Position: Q3 2020 in Review

Cetera Advisor Networks sold out of Adaptive Biotechnologies (ADPT) in Q3 2020, closing a stake of 575 shares — an estimated $28K sold.

Cetera Advisor Networks first reported a position in ADPT in Q2 2020 and held it in 1 quarter. The position peaked at $28K in Q2 2020. 206 funds tracked by Wall St. Rank hold ADPT as of Q3 2020.

  • Cetera Advisor Networks reported no remaining Adaptive Biotechnologies position as of Q3 2020 after selling out during the quarter.
  • Cetera Advisor Networks sold 575 Adaptive Biotechnologies shares in Q3 2020, an estimated $28K.
  • Cetera Advisor Networks first reported a position in Adaptive Biotechnologies in Q2 2020 and held it in 1 quarter.
  • Cetera Advisor Networks's Adaptive Biotechnologies position peaked at $28K in Q2 2020.
  • 206 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.